Senior Director, Commercial Accounting

Immunome, Inc.•Bothell, WA

9d•$250,111 - $290,621

About The Position

Immunome is a clinical-stage targeted oncology company developing targeted cancer therapies. The Senior Director, Commercial Accounting will lead the establishment and execution of commercial accounting operations as the company prepares to launch its first product. The role will build scalable accounting processes and an internal control framework covering revenue recognition, inventory and cost of goods sold (COGS), third-party logistics (3PL) accounting, and gross-to-net considerations, working closely with Commercial, Supply Chain, and Finance leadership. The position calls for hands-on experience supporting product launches in biotech or life sciences and the ability to work effectively in a fast-paced, pre-commercial or early-commercial environment. The successful candidate will combine technical accounting expertise with cross-functional collaboration, lead commercial accounting staff and/or external consultants as appropriate, and support commercial accounting reporting, audits, and systems implementation.

Requirements

Bachelor’s degree in Accounting or Finance.
10+ years of progressive accounting experience, including experience in a public company subject to SOX 404(b), or equivalent.
Significant experience in biotech, pharmaceutical, or life sciences, with direct exposure to commercial operations.
Demonstrated expertise in ASC 606 revenue recognition, inventory accounting, and cost of goods sold.
Hands-on experience working with 3PLs, CMOs, and distribution partners in a controlled environment.
Strong understanding of SOX internal controls, documentation standards, and audit processes.
Experience building or enhancing accounting processes in a lean, high-growth public company.
Excellent communication and cross-functional collaboration skills.
Ability to operate at both a strategic and detailed execution level.

Nice To Haves

CPA preferred.
Ideally 5+ years of experience in Commercial Accounting.
Experience supporting a first commercial product launch in a public company.
Experience scaling SOX processes post-commercialization.

Responsibilities

Own and implement ASC 606 revenue recognition policies, procedures, and control activities for product sales.
Develop a gross-to-net reserve model and oversee related accounting processes, including chargebacks, rebates, returns, Medicaid/Medicare, and other applicable government and commercial programs.
Oversee accounting for outsourced order-to-cash processes, ensuring accurate billing, revenue cut-off, cash application, and reconciliations.
Prepare and maintain technical accounting memos, internal control narratives, and process documentation for internal and external audits.
Collaborate with FP&A, Commercial, Market Access, Supply Chain, Legal, and IT to align accounting, forecasting, and operational execution.
Provide accounting guidance on commercial initiatives, pricing strategies, and distribution models in a SOX-controlled environment.
Lead and develop commercial accounting staff and/or external consultants, as appropriate for company size.
Prepare SEC reporting, audit committee materials, and internal management reporting related to commercial activities.
Serve as a primary external-auditor contact for commercial accounting, including walkthroughs, control testing, and issue remediation.
Own accounting for worldwide commercial and clinical inventory, including costing, overhead rate planning and application, variances, and inventory cost and quantity roll-forwards.
Direct review of monthly manufacturing accruals, partner with cross-functional teams on an accurate and timely financial close, and improve the accrual close cycle.
Establish SOX-compliant controls over inventory valuation, reserves, obsolescence, excess inventory, and physical counts.
Ensure reconciliation and completeness controls between operational systems, 3PL reports, and the general ledger.
Provide guidance for ERP and 3PL system implementations, including design, testing, internal controls, and audit readiness.